Skip to main content
Earnings Labs
CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc. (CTMX)

NASDAQ·Healthcare·Biotechnology

$3.30

+3.94%

Mkt Cap $498.55M

Analyst Ratings

Buy

9

Hold

0

Sell

0

Price Target (22 analysts)

$11.00

Range $6.00$16.00

Implied Upside

+233.8%

Consensus $11.00 vs current $3.30